All News

Two pediatric oncology nurses created a food pantry to ease food insecurity, providing weekly groceries that help families focus on their child's cancer care.

Twelve years after cancer, one survivor explains why every cancer-free anniversary deserves celebration and why gratitude never has an expiration date.

Actress and author Michelle Monaghan shares her melanoma journey, the importance of early detection and her new book empowering kids to prioritize skin health.

Zachary Rieke, of MD Anderson Cancer Center, pioneered a screening tool to identify and address food insecurity among pain management patients.

Susan Rux, RN, of Fox Chase Cancer Center, leads federally funded research to expand clinical trial access for underrepresented kidney cancer patients while mentoring the next generation of oncology nurses.

After a $15,000 insurance bill delayed her lymphoma treatment, one survivor shares why self-advocacy is essential for every cancer patient.

Anna Cummings, BSN, RN, of Memorial Sloan Kettering Cancer Center, manages complex immunotherapy trials while building deep, trusting bonds with her cancer patients.

Get expert answers to the top pancreatic cancer questions, including symptoms, surgery, new treatments, hereditary risk and early diagnosis.

FDA approves Tregzi, a new cell therapy that helps reduce chronic graft-versus-host disease after donor stem cell transplant in adults with blood cancers.

Living with follicular lymphoma can complicate other medical decisions. One survivor shares how cancer uncertainty delayed treatment for hip pain.

AURORA, a phase 3 trial, is testing aglatimagene besadenovec plus Keytruda in patients with lung cancer who progressed on immunotherapy.

Catina Pitzen, BSN, RN, of Eisai US, leads Columbus P.ink Day, helping breast cancer survivors transform surgical scars into meaningful tattoo art.

Leslie Waltke's new podcast explores how cancer labels like 'survivor,' 'patient' and 'victim' evolved — and why no single word fits everyone.

Bradford Aldrich, RN, of Brigham and Women's Hospital, creates moments of joy and connection for cancer patients through small gestures and a journal project that lets patients heal one another.

After four ovarian cancer recurrences, one survivor reflects on resilience, gratitude, and the life lessons that transformed her cancer journey.

Tracy Peck, RN, of Urology Specialists of the Carolinas, doubled her clinic's patient volume while creating "Elevator Bob," a peer support initiative that's now reached communities nationwide.

A UF Health oncologist answers the most common questions about cell therapy, from who qualifies to how it differs from chemotherapy.

Amanda Smith, registered nurse, of Huntsman Cancer Institute, helped lead novel research on MPN drug safety during pregnancy, earning co-authorship and her mentor's highest praise.

Nicholas Hornstein, MD, PhD discusses ctDNA in colorectal cancer, the INTERCEPT-TT trial, building Northwell's GI oncology program, and what better drugs will look like.

A cancer survivor reflects on the receptionists, medical assistants and nurses whose kindness made treatment more manageable and less frightening.

Aurora Relampagos blends clinical expertise with compassion, leading scheduling innovations that cut wait times while mentoring colleagues and staff.

He thought CAR-T therapy marked the end of cancer. Months later, another diagnosis revealed the power of faith, hope and resilience.

Diagnosed with Hodgkin lymphoma at 18, Steve Garraty shares how survivorship, gratitude and purpose emerged from life's hardest chapter.

14 years after a rare lymphoma diagnosis, Edward Miskie answers real questions on survivorship, caregiving and life after cancer treatment.

After a kidney lesion proved unlikely to be cancer, a survivor embraces self-care, friendship and new opportunities with renewed gratitude and joy.

FDA approves Trodelvy alone or with Keytruda for the first-line treatment of adults with unresectable locally advanced or metastatic triple-negative breast cancer.

Susan Yaguda, oncology nurse at Atrium Health Levine Cancer Institute, transforms cancer care by treating the whole person — mind, body, and spirit — one patient at a time.

FDA approves Ibrance with trastuzumab and endocrine therapy for maintenance treatment of HR-positive, HER2-positive metastatic breast cancer.